Table 1.
The relationship between DPT expression and clinicopathological characteristics in TCGA cohort.
| Characteristics | Expression of DPT, number (%) | ||
|---|---|---|---|
| Low expression (n = 538) (%) | High expression (n = 539) (%) | P-value | |
| Age at diagnosis, y | |||
| Mean ± SD | 59.19 ± 13.50 | 57.64 ± 12.87 | 0.055 |
| ≤60 y | 279 (51.86) | 316 (58.63) | 0.026* |
| >60 y | 259 (48.14) | 223 (41.37) | |
| Subtype | <0.001* | ||
| Luminal A | 199(36.99) | 298 (55.29) | |
| Luminal B | 137(25.46) | 59 (10.95) | |
| Basal-like | 111(20.63) | 60 (11.13) | |
| HER-2+ | 34(6.32) | 44 (8.16) | |
| Tumor size in cm | |||
| ≤2 cm | 121 (22.49) | 154 (28.57) | 0.023* |
| >2 cm | 415 (77.14) | 384 (71.24) | |
| Lymph node metastasis | 0.122 | ||
| ≤3 metastatic sites | 440 (81.63) | 423 (78.48) | |
| >3 metastatic sites | 87 (16.17) | 107 (19.85) | |
| Metastasis | 0.585 | ||
| M0 | 458 (85.13) | 438 (81.26) | |
| M1 | 12 (2.23) | 9 (1.67) | |
| AJCC disease stage | |||
| I + II | 402 (74.72) | 391 (72.54) | 0.405 |
| III + IV | 127 (23.61) | 139 (25.79) | |
*P-value < 0.05.